SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMARDA, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.562
AS - Asia 1.474
EU - Europa 959
SA - Sud America 185
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 7.206
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.497
SG - Singapore 547
CN - Cina 478
DE - Germania 210
UA - Ucraina 169
GB - Regno Unito 155
BR - Brasile 153
IT - Italia 128
TR - Turchia 126
HK - Hong Kong 106
VN - Vietnam 106
FI - Finlandia 95
SE - Svezia 55
RU - Federazione Russa 39
CA - Canada 36
FR - Francia 28
IN - India 25
JP - Giappone 24
MX - Messico 24
PL - Polonia 18
NL - Olanda 15
AR - Argentina 14
ZA - Sudafrica 12
BE - Belgio 11
ID - Indonesia 11
BD - Bangladesh 9
LT - Lituania 9
ES - Italia 8
UZ - Uzbekistan 8
IQ - Iraq 7
AT - Austria 5
CO - Colombia 5
PK - Pakistan 5
SA - Arabia Saudita 5
EC - Ecuador 4
IE - Irlanda 4
TN - Tunisia 4
BG - Bulgaria 3
IL - Israele 3
MA - Marocco 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IR - Iran 2
JM - Giamaica 2
PY - Paraguay 2
RO - Romania 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
SN - Senegal 1
SV - El Salvador 1
Totale 7.206
Salva come PNG Salva come JPEG
Città #
Dallas 798
Fairfield 475
Woodbridge 431
Ashburn 354
Singapore 351
Houston 252
Jacksonville 188
Seattle 178
Chandler 173
Cambridge 161
Beijing 160
Ann Arbor 139
Santa Clara 137
Wilmington 136
Hong Kong 105
New York 75
Munich 70
Los Angeles 64
Nanjing 64
Izmir 62
San Diego 47
Milan 43
Princeton 40
Boardman 33
Shanghai 33
Helsinki 32
Ho Chi Minh City 32
Dong Ket 26
Turku 26
London 25
Ferrara 24
Tokyo 24
Dearborn 22
Bremen 20
Addison 16
Hebei 16
Mcallen 16
Mexico City 16
Shenyang 16
São Paulo 16
Brooklyn 14
Hanoi 14
Nanchang 14
Orem 13
Warsaw 13
Auburn Hills 12
Buffalo 12
Hefei 12
Montréal 12
Brussels 11
Denver 11
Changsha 10
San Francisco 10
Tianjin 10
Atlanta 9
Falkenstein 9
Frankfurt am Main 9
Norwalk 9
Philadelphia 9
Stockholm 9
Manchester 8
Boston 7
Chennai 7
Jiaxing 7
Jinan 7
Johannesburg 7
Montreal 7
Moscow 7
Ningbo 7
Padova 7
Tashkent 7
Amsterdam 6
Bexley 6
Charlotte 6
Chicago 6
Mountain View 6
New Delhi 6
Rio de Janeiro 6
Toronto 6
Falls Church 5
Guangzhou 5
Indiana 5
Phoenix 5
Poplar 5
Tappahannock 5
Ankara 4
Baghdad 4
Biên Hòa 4
Bologna 4
Da Nang 4
Dublin 4
Ninh Bình 4
Porto Alegre 4
Querétaro 4
Redwood City 4
Rome 4
San Mateo 4
Augusta 3
Carney 3
Curitiba 3
Totale 5.331
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 957
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 317
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 221
A new ligand for the urotensin II receptor 219
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 206
null 205
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 201
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 193
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 190
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 189
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 184
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 181
Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle 179
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 179
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 178
Pharmacological characterisation of novel kinin B2 receptor ligands 176
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 176
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 171
Structure-activity study at positions 3 and 4 of human neuropeptide S. 168
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 164
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 161
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 159
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 159
Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors 159
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 156
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 156
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 153
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 152
Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol 152
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 149
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 149
Structure-activity relationship study on human urotensin II 148
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems 135
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives 118
null 94
null 87
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 87
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 86
null 78
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 49
Totale 7.241
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 881
Totale 30.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021330 0 0 0 0 0 50 31 62 13 59 61 54
2021/2022456 17 52 54 5 31 14 31 26 13 41 41 131
2022/2023439 43 26 15 51 79 59 34 35 56 1 21 19
2023/2024266 21 32 15 8 8 59 11 21 3 4 16 68
2024/2025922 35 27 105 23 108 92 23 36 123 74 137 139
2025/20262.248 292 274 782 322 397 181 0 0 0 0 0 0
Totale 7.241